{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:31:30Z","timestamp":1791124290301,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260274-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>How often effect modification analyses in individual participant data meta-analyses (IPDMAs) are prespecified and consistently reported in protocols and corresponding reports remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260274-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the planning of effect modification analyses in IPDMA protocols and evaluate their concordance with corresponding published reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260274-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>In this systematic review, Medline, Embase, the Cochrane Database of Systematic Reviews, and PROSPERO were searched for protocols of IPDMAs of randomized clinical trials from database inception until December 31, 2021, and their corresponding published study reports until January 31, 2024. Paired reviewers independently identified eligible protocols and reports and extracted data. Planning and reporting characteristics of effect modification analyses were summarized, and matched protocol-report pairs were compared for concordance in prespecification of effect modification analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260274-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Of 356 protocols, 336 (94.4%) had planned effect modification analyses (median, 6 [IQR, 4-10] per protocol). Of those, 12 (3.6%) stated an anticipated direction, 176 (52.4%) planned interaction tests, and 37 (11.0%) planned within-trial analyses. Of 265 protocols using continuous variables as effect modifiers, 15 (5.7%) planned to treat all continuous variables as continuous and 72 (27.2%) planned to categorize all variables without providing justification thresholds. Of 166 identified reports, 149 (89.8%) reported effect modification analyses (median, 7 [IQR, 3-9] per study report). Among those 149 reports, 84 (56.4%) reported prespecified effect modification analyses, 125 (83.9%) reported interaction tests, and 3 (2.0%) stated anticipated effect directions. Among 133 reports using continuous variables, 87 (65.4%) used specified thresholds without providing justification for chosen cut points. Among 166 report-protocol pairs, 32 (19.3%) showed agreement on the number and factors of effect modification analyses. Of 124 mismatched pairs, 95 (76.6%) omitted 1 or more planned effect modification analyses in reports (74 [59.7%] without explanation), and 74 (59.7%) added unplanned effect modification analyses. Among 156 comparable pairs, 15 reports (9.6%) claimed prespecification for effect modification analyses absent from protocols and 84 reports (53.8%) failed to claim prespecification for effect modification analyses prespecified in protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260274-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this systematic review of IPDMAs, protocols and reports often failed to prespecify anticipated effect modification directions, distinguish within-trial from between-trial analyses, and appropriately handle continuous variables. Concordance between protocols and reports was poor, with frequent omission of planned and addition of unplanned effect modification analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.8810","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:30:28Z","timestamp":1776958228000},"page":"e268810","source":"Crossref","is-referenced-by-count":1,"title":["Effect Modification Analyses in Individual Participant Data Meta-Analyses"],"prefix":"10.1001","volume":"9","author":[{"given":"Ya","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Medical Dataology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China"},{"name":"National Institute of Health and Medical Big Data, Jinan, China"},{"name":"Haihe Laboratory of Modern Chinese Medicine, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Chongqing Municipality Clinical Research Center for Geriatrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminreza","family":"Asadollahifar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven-University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Daneshmand","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Hamilton, Ontario, Canada"},{"name":"Department of Surgery, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yao","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwen","family":"Yang","sequence":"additional","affiliation":[{"name":"Haihe Laboratory of Modern Chinese Medicine, Tianjin, China"},{"name":"Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhong","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Medical Dataology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China"},{"name":"National Institute of Health and Medical Big Data, Jinan, China"},{"name":"Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China"},{"name":"Key Laboratory of Evidence-Based Medicine of Gansu Province, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Haihe Laboratory of Modern Chinese Medicine, Tianjin, China"},{"name":"Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"MAGIC Evidence Ecosystem Foundation, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"zoi260274r1","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? updating criteria to evaluate the credibility of subgroup analyses.","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"key":"zoi260274r2","doi-asserted-by":"publisher","first-page":"g4539","DOI":"10.1136\/bmj.g4539","article-title":"Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.","volume":"349","author":"Kasenda","year":"2014","journal-title":"BMJ"},{"issue":"32","key":"zoi260274r3","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"issue":"1","key":"zoi260274r4","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-3668","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement: explanation and elaboration.","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"issue":"15","key":"zoi260274r5","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/sim.8516","article-title":"Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: statistical recommendations for conduct and planning.","volume":"39","author":"Riley","year":"2020","journal-title":"Stat Med"},{"issue":"2","key":"zoi260274r6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/ije\/dyy239","article-title":"How often can meta-analyses of individual-level data individualize treatment? a meta-epidemiologic study.","volume":"48","author":"Schuit","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"zoi260274r7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-016-0744-x","article-title":"Cumulative subgroup analysis to reduce waste in clinical research for individualised medicine.","volume":"14","author":"Song","year":"2016","journal-title":"BMC Med"},{"key":"zoi260274r8","doi-asserted-by":"publisher","first-page":"d1569","DOI":"10.1136\/bmj.d1569","article-title":"The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review.","volume":"342","author":"Sun","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"zoi260274r9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer\u2019s guide to subgroup analyses.","volume":"116","author":"Oxman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi260274r10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users\u2019 guide to the medical literature.","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"issue":"Pt A","key":"zoi260274r11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cct.2015.06.012","article-title":"A decade of individual participant data meta-analyses: A review of current practice.","volume":"45","author":"Simmonds","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"zoi260274r12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0163278702025001006","article-title":"To IPD or not to IPD? advantages and disadvantages of systematic reviews using individual patient data.","volume":"25","author":"Stewart","year":"2002","journal-title":"Eval Health Prof"},{"issue":"1","key":"zoi260274r13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0895-4356(01)00414-0","article-title":"A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis.","volume":"55","author":"Lambert","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"zoi260274r14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12874-016-0146-y","article-title":"A scoping review of indirect comparison methods and applications using individual patient data.","volume":"16","author":"Veroniki","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"zoi260274r15","doi-asserted-by":"publisher","first-page":"j1390","DOI":"10.1136\/bmj.j1390","article-title":"Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review.","volume":"357","author":"Nevitt","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"zoi260274r16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12916-020-01591-0","article-title":"Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study.","volume":"18","author":"Gao","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"zoi260274r17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12874-019-0817-6","article-title":"Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study.","volume":"19","author":"Belias","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"zoi260274r18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1017\/S0266462308080471","article-title":"Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses.","volume":"24","author":"Koopman","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"key":"zoi260274r19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jclinepi.2021.06.019","article-title":"Prespecification of subgroup analyses and examination of treatment-subgroup interactions in cancer individual participant data meta-analyses are suboptimal.","volume":"138","author":"Gao","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"9456","key":"zoi260274r20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(05)17790-3","article-title":"Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"key":"zoi260274r21","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting.","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"zoi260274r22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jclinepi.2019.05.014","article-title":"A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses.","volume":"113","author":"Schandelmaier","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"zoi260274r23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jclinepi.2007.01.018","article-title":"A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses.","volume":"60","author":"Koopman","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"zoi260274r24","doi-asserted-by":"publisher","first-page":"j573","DOI":"10.1136\/bmj.j573","article-title":"Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?","volume":"356","author":"Fisher","year":"2017","journal-title":"BMJ"},{"issue":"71","key":"zoi260274r25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"736","key":"zoi260274r26","doi-asserted-by":"publisher","first-page":"n736","DOI":"10.1136\/bmj.n736","article-title":"The methodological quality of individual participant data meta-analysis on intervention effects: systematic review.","volume":"373","author":"Wang","year":"2021","journal-title":"BMJ"},{"key":"zoi260274r27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1553","article-title":"Credibility of claims of subgroup effects in randomised controlled trials: systematic review.","volume":"344","author":"Sun","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"zoi260274r28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea.","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"issue":"7549","key":"zoi260274r29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables.","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"zoi260274r30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1037\/1082-989X.7.1.19","article-title":"On the practice of dichotomization of quantitative variables.","volume":"7","author":"MacCallum","year":"2002","journal-title":"Psychol Methods"},{"key":"zoi260274r31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082440","article-title":"Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide.","volume":"390","author":"Lopez-Ayala","year":"2025","journal-title":"BMJ"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848105\/gao_2026_oi_260274_1776356620.91353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:30:28Z","timestamp":1776958228000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848105"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.8810","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}